ED arrests former Andhra Bank director in Sterling Biotech loan fraud case

Published On 2018-01-15 05:00 GMT   |   Update On 2018-01-15 05:00 GMT



This is the second arrest in the case after the agency in November last year held Delhi-based businessman Gagan Dhawan from here. Garg has been arrested under the Prevention of Money Laundering Act (PMLA) and is expected to be produced before a special court. Garg has been named as an accused in the case by the ED and the CBI.


Read also: Sterling Biotech Case: Court asks ED reply on Gagan Dhawan bail plea


Read also: ED attaches Delhi businessman property in Sterling Biotech money laundering case


The ED registered a money laundering case in this instance after taking cognizance of an earlier CBI FIR.


The agency said it found during probe that “certain entries” in a diary seized by the Income Tax Department in 2011 showed various cash payments amounting to Rs. 1.52 crore made to one “Mr. Garg, Director, Andhra Bank” between 2008- 2009 by the Sandesara brothers. It said, “various cash payments were made to Garg, as reflected in the said entries, on the instructions of Sandesara brothers, by withdrawing cash from the bank accounts of several benami companies of the Sandesara brothers“.


The ED had alleged that Garg had infused several crores of his unaccounted cash in various companies through many Kolkata based bogus shell companies with the help of cash/cheque entry operators in Kolkata to launder the proceeds of crime obtained by him from the Sandesaras.


The CBI had booked Sterling Biotech, its directors Chetan Jayantilal Sandesara, Dipti Chetan Sandesara, Rajbhushan Omprakash Dixit, Nitin Jayantilal Sandesara and Vilas Joshi, chartered accountant Hemant Hathi, Garg and some unidentified persons in connection with the alleged bank fraud case. It had alleged that the company had taken loans of over Rs. 5,000 crores from a consortium led by Andhra Bank which had turned into non-performing assets.


Read also: Non-bailable warrants issued against Sterling Biotech directors in Rs 5,000 crore fraud case


The FIR had also alleged that the total pending dues of the group companies were Rs. 5,383 crore as on December 31, 2016.


Read also: CBI FIR against Sterling Biotech for Rs 5,000 cr loan default

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News